These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 35285446)
1. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report. Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446 [TBL] [Abstract][Full Text] [Related]
2. Mixed Infections (Mucormycosis, Actinomycosis and Candidiasis) Leading to Maxillary Osteomyelitis in a Diabetic Mellitus Patient in Post COVID Phase: First Case Report. Jawanda MK; Narula R; Gupta S; Sharma V; Sidhu SK; Kaur N Acta Medica (Hradec Kralove); 2021; 64(4):218-223. PubMed ID: 35285444 [TBL] [Abstract][Full Text] [Related]
3. Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series. Urias-Barreras CM; Rodríguez-Archilla A; Canizalez-Roman A; Bastidas DA; León-Sicairos NM J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101615. PubMed ID: 37648209 [TBL] [Abstract][Full Text] [Related]
4. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital. Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183 [TBL] [Abstract][Full Text] [Related]
5. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review. Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498 [TBL] [Abstract][Full Text] [Related]
6. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India. Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134 [TBL] [Abstract][Full Text] [Related]
7. [Mucormycosis of the face associated with aspergillosis in the diabetic patient. Diagnostic and therapeutic considerations]. Bonfils P; Trotoux J Ann Otolaryngol Chir Cervicofac; 1989; 106(6):327-9. PubMed ID: 2817670 [TBL] [Abstract][Full Text] [Related]
8. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario. Menia R; Raychaudhuri S; Agarwal C; Taneja J Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540 [TBL] [Abstract][Full Text] [Related]
12. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Song G; Liang G; Liu W Mycopathologia; 2020 Aug; 185(4):599-606. PubMed ID: 32737747 [TBL] [Abstract][Full Text] [Related]
13. COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent. Bhargava D; Ahirwal R; Dubey S; Gurjar P; Pandey A; Beena S; Koneru G Head Neck Pathol; 2022 Sep; 16(3):645-650. PubMed ID: 34751896 [TBL] [Abstract][Full Text] [Related]
14. Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature. Chermetz M; Gobbo M; Rupel K; Ottaviani G; Tirelli G; Bussani R; Luzzati R; Di Lenarda R; Biasotto M Mycopathologia; 2016 Oct; 181(9-10):723-33. PubMed ID: 27350324 [TBL] [Abstract][Full Text] [Related]